Cerebral Infarctions Completed Phase 3 Trials for Cilostazol (DB01166)

Also known as: Cerebral Infarct / Cerebral Infarction / Stroke NOS / Infarct cerebral

IndicationStatusPhase
DBCOND0047013 (Cerebral Infarctions)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00766545Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.Prevention
NCT00202020Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of StrokePrevention